Without proper controls, it is impossible to separate the peptide effect from natural healing (remembering that 85% of acute herniations resolve on their own), placebo effects, concurrent treatments, and time
April 2026 Category 2 Update On April 15, 2026, the FDA confirmed removal of injectable GHK-Cu from Category 2 because the original nominations were withdrawn
(Think of it this way: Would you just take antidepressants or pain meds willy-nilly?) Peptides are out there as miracle cures, and I dont buy into that, Dr
Research shows that GHK-Cu can improve angiogenesis in the nervous system, boost nerve outgrowth, and reduce inflammation in the central nervous system
Encourages skin health and post-activity repair
Because Retatrutide and Cagrilintide barely touch the same receptors, their effects stack instead of cancel